Results 41 to 50 of about 774,099 (307)

Effects of hemodialysis therapy on sit-to-walk characteristics in end stage renal disease patients [PDF]

open access: yes, 2012
Patients with end stage renal diseases (ESRD) undergoing hemodialysis (HD) have high morbidity and mortality due to multiple causes; one of which is dramatically higher fall rates than the general population.
Abdel-Rahman, Emaad   +3 more
core   +2 more sources

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Modeling Outcome of Patients on Renal Replacement Therapy [PDF]

open access: yes, 2008
The incidence of end-stage renal disease is increasing and therefore, the number of patients requiring renal replacement therapy (RRT), renal dialysis or renal transplantation (RTx), has been rising.
Liem, Y.S. (Ylian Serina)
core   +10 more sources

The End-Stage Renal Disease Program [PDF]

open access: yes, 1978
By the mid 1960\u27s it had been clearly demonstrated that the lives of people with total, permanent kidney failure could be indefinitely prolonged with the artificial kidney and that an acceptable proportion of kidney transplants would be successful ...
Stacy, William K.
core   +1 more source

Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients with Chronic Kidney Disease

open access: yesJournal of the American Medical Association (JAMA), 2011
Context High levels of the phosphate regulating hormone, fibroblast growth factor 23 (FGF23), associate with mortality in patients with end-stage renal disease (ESRD), but little is known about its relationship with adverse outcomes in the much larger ...
T. Isakova   +19 more
semanticscholar   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease: An Analysis of the US Renal Data System

open access: yesJAMA cardiology, 2019
Importance Cardiovascular disease (CVD) is a leading cause of death among patients with end-stage renal disease (ESRD). Young adult (ages 22-29 years) have risks for ESRD-associated CVD that may vary from other ages. Objective To test the hypothesis that
Zubin J. Modi   +10 more
semanticscholar   +1 more source

The Fate (Outcome) of Clinically Apparent Single Lesion and Oligofocal Nephroblastomatosis Treated According to SIOP/GPOH Protocols for Wilms Tumor

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background The management of clinically apparent single lesions or oligofocal nephroblastomatosis, a facultative precursor of nephroblastoma, remains debated. Methods We retrospectively analyzed 37 patients with clinically apparent single or oligofocal nephroblastomatosis (two to three lesions per kidney) among 2347 patients registered between
Nils Welter   +17 more
wiley   +1 more source

Global Challenge of Early Detection and Management of Chronic Kidney Disease [PDF]

open access: yes, 2017
Chronic Kidney Disease (CKD) is a global health burden with a high economic cost to the health system and is an independent risk factor for cardiovascular disease (CVD), not only in the developed country but also in developing country like Indonesia.1,2
Fauziyati, A. (Ana)
core   +2 more sources

Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971–2015

open access: yesArthritis & Rheumatology, 2016
End‐stage renal disease (ESRD) is a major consequence of lupus nephritis, but how this risk has changed over time is unknown. We conducted this systematic review to examine changes in ESRD among adults with lupus nephritis from 1971 to 2015 and to ...
M. Tektonidou   +2 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy